Trials / Completed
CompletedNCT05821179
Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 36 (actual)
- Sponsor
- Fayoum University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to verify the role of salivary LINC00657 as a diagnostic marker in oral squamous cell carcinoma (OSCC) patients as compared to oral lichen planus (OLP) (as an example of oral potentially malignant lesions) and normal individuals, and to show its relation to miR-106a. A total of 36 participants were included.
Detailed description
This study was designed to verify the role of salivary LINC00657 as a diagnostic marker in oral squamous cell carcinoma (OSCC) patients as compared to oral lichen planus (OLP) (as an example of oral potentially malignant lesions) and normal individuals, and to show its relation to miR-106a. A total of 36 participants were included, subdivided into 3 groups: Group I: 12 patients diagnosed with OSCC. Group II: 12 patients diagnosed with OLP. Group III: 12 systemically free individuals with no oral mucosal lesions. statistical analysis and ROC analysis were performed
Conditions
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-01-01
- Completion
- 2023-02-25
- First posted
- 2023-04-20
- Last updated
- 2023-04-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05821179. Inclusion in this directory is not an endorsement.